Hologic Inc (HOLX) Stock Price, Quote & News

Company Profile

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, an...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 508 263 2900

Website: www.hologic.com

Address:

250 Campus Drive, Marlborough, United States

ZacksResearch Jun. 16 at 1:04 PM

$HOLX: Can it weather the storm despite a turbulent year ahead? 🌩️ Hologic's shares have dropped 10.4% over six months while the stock trades at a forward P/S of 3.42x, above its sector, with a Zacks Rank #4 (Sell). Understand the risks before investing in HOLX 👉 https://www.zacks.com/commentary/2503122/hologics-margin-stability-amid-tariffs-whats-behind-the-confidence?cid=sm-stocktwits-2-2503122-body&ADID=SYND_STOCKTWITS_TWEET_2_2503122_BODY

0 · Reply

ZacksResearch Jun. 16 at 11:35 AM

Margin strength from $HOLX — even with China weakness and tariffs? Diagnostic momentum and high-margin acquisitions are keeping the profit engine running. Full breakdown here 👉 https://www.zacks.com/stock/news/2503122/hologics-margin-stability-amid-tariffs-whats-behind-the-confidence?cid=sm-stocktwits-2-2503122-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2503122_TEASER

0 · Reply

ZacksResearch Jun. 11 at 1:21 PM

$HOLX navigating headwinds with adjustments in core businesses 🌍💼 📉 Excludes $50M HIV testing business in Africa due to halted USAID funding 💰 Facing $20M-$25M tariff-related cost hikes 🔬 Diagnostics segment momentum driven by strong demand for key assays and growing service business Discover the full analysis here 👉 https://www.zacks.com/commentary/2494076/can-hologic-lean-on-its-strengths-in-a-tough-macroeconomic-climate?cid=sm-stocktwits-2-2494076-body&ADID=SYND_STOCKTWITS_TWEET_2_2494076_BODY

0 · Reply

ZacksResearch Jun. 11 at 11:31 AM

Can $HOLX weather the storm — or thrive in it? Growth in Diagnostics and Breast Health service segments is helping offset global macro headwinds. Full story here 👉 https://www.zacks.com/stock/news/2494076/can-hologic-lean-on-its-strengths-in-a-tough-macroeconomic-climate?cid=sm-stocktwits-2-2494076-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2494076_TEASER

0 · Reply

ZacksResearch Jun. 9 at 1:35 PM

$HOLX surges 13.3% — what's fueling the rally? 🚀 🔹 Hologic turned down a non-binding $16.7B takeover bid, boosting investor confidence. 🔹 New data on its Breast Cancer Index test reveals significant clinical impact. 🔹 Trading at a P/S of 3.40X, it's cheaper than its five-year median. Is it time to dive in or wait for a dip? Full analysis here 👉 https://www.zacks.com/commentary/2490517/hologic-climbs-13-in-a-month-how-should-you-play-the-stock?cid=sm-stocktwits-2-2490517-body&ADID=SYND_STOCKTWITS_TWEET_2_2490517_BODY

0 · Reply

ZacksResearch Jun. 9 at 1:33 PM

0 · Reply

ZacksResearch Jun. 9 at 11:45 AM

$HOLX up 13% in a month — is this the start of something bigger? A rejected $16.7B buyout offer and fresh BCI data are driving momentum, but what’s the real investment case now? Full outlook breakdown here 👉 https://www.zacks.com/stock/news/2490517/hologic-climbs-13-in-a-month-how-should-you-play-the-stock?cid=sm-stocktwits-2-2490517-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2490517_TEASER

0 · Reply

Thefunnyinvestor Jun. 5 at 9:33 PM

$HOLX

0 · Reply

Truman2332 Jun. 4 at 3:01 PM

$HOLX still holding my short position… being patient for mid 50s

1 · Reply

Traderoca Jun. 4 at 2:31 PM

$HOLX

0 · Reply

Hologic Joins NEST Governance Committee to Advance the Use of Real-World Data in Medical Device Evaluation

May 27, 2025, 3:48 PM EDT - 24 days ago

Why Is Diagnostic Firm Hologic Stock Trading Higher On Tuesday?

May 27, 2025, 1:05 PM EDT - 25 days ago

Hologic rejects $16 billion take-private proposal from TPG and Blackstone, Financial Times reports

BX TPG

May 22, 2025, 5:05 PM EDT - 4 weeks ago

Hologic to Present New Data at ASCO 2025 Reinforcing the Practice-Changing Role of the Breast Cancer Index® Test in Helping to Deliver More Personalized Care to Patients

May 13, 2025, 4:10 PM EDT - 5 weeks ago

Hologic to Webcast Presentations at Upcoming Investor Conferences

May 6, 2025, 5:39 PM EDT - 6 weeks ago

Hologic: Soft Performance, But Cheap Enough

May 1, 2025, 8:24 PM EDT - 7 weeks ago

Hologic, Inc. (HOLX) Q2 2025 Earnings Call Transcript

May 1, 2025, 6:58 PM EDT - 7 weeks ago

Medical equipment maker Hologic lowers annual profit forecast on tariff uncertainty

May 1, 2025, 4:01 PM EDT - 7 weeks ago

Hologic Announces Financial Results for Second Quarter of Fiscal 2025

Apr 25, 2025, 4:25 AM EDT - 2 months ago

Cellulite Treatment Market Trends, Growth Opportunities and Shares 2025-2030; Featuring Key Players - Hologic (Cynosure), Merz Pharma, Syneron Medical, Zimmer Aesthetics & More

Apr 24, 2025, 8:10 AM EDT - 2 months ago

Groundbreaking New Data on Hologic's AI-Powered Mammography Technology to Be Presented at SBI

Apr 22, 2025, 8:08 AM EDT - 2 months ago

Hologic Details Environmental, Social and Governance Efforts — Including Expanded Environmental Ambitions — in New Sustainability Report

Apr 4, 2025, 4:15 PM EDT - 2 months ago

Wayde McMillan Elected to Hologic Board of Directors

Apr 3, 2025, 4:30 PM EDT - 2 months ago

Hologic to Announce Financial Results for the Second Quarter of Fiscal 2025 on Thursday, May 1, 2025

Feb 25, 2025, 8:15 AM EST - 4 months ago

Hologic to Webcast Presentation at the Raymond James 46th Annual Institutional Investors Conference

Feb 20, 2025, 3:00 AM EST - 4 months ago

Hologic Obtains CE Mark for Affirm® Contrast Biopsy Software

Feb 18, 2025, 8:08 AM EST - 4 months ago

Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay

Feb 5, 2025, 10:06 PM EST - 4 months ago

Hologic, Inc. (HOLX) Q1 2025 Earnings Call Transcript

Feb 5, 2025, 5:56 PM EST - 4 months ago

Hologic cuts annual revenue forecast on weak demand for breast health products

Feb 5, 2025, 4:01 PM EST - 4 months ago

Hologic Announces Financial Results for First Quarter of Fiscal 2025

Jan 21, 2025, 8:00 AM EST - 5 months ago

New Report Reveals Alarming Decline in Women's Cancer Testing Worldwide

Jan 17, 2025, 1:28 PM EST - 5 months ago

Hologic: Reasonably, But Not Compellingly Valued

Jan 12, 2025, 4:00 PM EST - 5 months ago

Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2025

Jan 7, 2025, 4:04 PM EST - 5 months ago

Hologic to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 6, 2025, 4:15 PM EST - 5 months ago

Hologic to Announce Financial Results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025

Jan 6, 2025, 8:05 AM EST - 5 months ago

Hologic Completes Acquisition of Gynesonics, Inc.

Jan 3, 2025, 12:06 PM EST - 6 months ago

Healthcare has 'been so bad, maybe it's gonna be good' in 2025, says Mizuho's Jared Holz

ABT BMY LLY NVO UNH XBI XLV

Dec 18, 2024, 8:08 AM EST - 6 months ago

Hologic to Contribute to H5N1 Bird Flu Test Development via Agreement Issued by CDC

Dec 10, 2024, 4:01 PM EST - 6 months ago

Hologic Statement on USPSTF Draft Cervical Cancer Screening Guidelines

Dec 9, 2024, 4:05 PM EST - 6 months ago

Martin Madaus Elected to Hologic Board of Directors

Dec 9, 2024, 8:05 AM EST - 6 months ago

New Data To Be Presented at SABCS 2024 Investigates the Potential Role of the Breast Cancer Index® Test in Identifying Patients With Minimal Risk of Distant Recurrence

Dec 2, 2024, 8:08 AM EST - 7 months ago

Hologic Presents New Research Demonstrating How Its Breast Imaging AI Solution Performs Similarly Across Diverse Populations

Nov 25, 2024, 8:22 AM EST - 7 months ago

Hologic Invites Attendees to Step Into the Future of Breast Health and AI at RSNA 2024

Nov 4, 2024, 7:26 PM EST - 8 months ago

Hologic, Inc. (HOLX) Q4 2024 Earnings Call Transcript

Nov 4, 2024, 4:01 PM EST - 8 months ago

Hologic Announces Financial Results for Fourth Quarter of Fiscal 2024

Oct 19, 2024, 2:00 PM EDT - 8 months ago

Hologic to acquire Gynesonics in $350M deal to boost Fibroid treatments

Oct 14, 2024, 2:07 PM EDT - 8 months ago

Hologic Adds Gynesonics' Sonata System In $350M Acquisition To Boost Fibroid Treatments

Oct 14, 2024, 8:05 AM EDT - 8 months ago

Hologic to Acquire Gynesonics, Developer of Minimally Invasive Solutions for Women's Health

Oct 4, 2024, 8:22 AM EDT - 9 months ago

Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2024 on Monday, November 4, 2024

Oct 1, 2024, 9:12 AM EDT - 9 months ago

Hologic CEO Steve MacMillan on breast cancer detection, future of AI-powered diagnostics

Sep 30, 2024, 9:17 AM EDT - 9 months ago

Hologic Unveils #BustTheMyth Campaign to Debunk Breast Cancer Myths and Empower Women This Breast Cancer Awareness Month

Aug 29, 2024, 8:08 AM EDT - 10 months ago

Hologic to Webcast Presentation at the Morgan Stanley 22nd Annual Global Healthcare Conference

Jul 30, 2024, 12:50 PM EDT - 11 months ago

Hologic CEO on earnings beat: our Covid work has 'turbocharged' diagnostics business

Jul 30, 2024, 9:05 AM EDT - 11 months ago

Hologic Analysts Boost Their Forecasts After Q3 Results

Jul 29, 2024, 8:40 PM EDT - 11 months ago

Hologic, Inc. (HOLX) Q3 2024 Earnings Call Transcript

Jul 29, 2024, 6:23 PM EDT - 11 months ago

Hologic quarterly profit rises on strong demand for its women's health products

Jul 29, 2024, 4:01 PM EDT - 11 months ago

Hologic Announces Financial Results for Third Quarter of Fiscal 2024

Jul 25, 2024, 8:19 AM EDT - 11 months ago

Hologic Completes Acquisition of Endomagnetics Ltd

Jul 9, 2024, 4:05 AM EDT - 1 year ago

72 Million American Women Have Skipped or Delayed Vital Screenings

Jul 2, 2024, 8:22 AM EDT - 1 year ago

Hologic to Announce Financial Results for the Third Quarter of Fiscal 2024 on Monday, July 29, 2024

ZacksResearch Jun. 16 at 1:04 PM

0 · Reply

ZacksResearch Jun. 16 at 11:35 AM

0 · Reply

ZacksResearch Jun. 11 at 1:21 PM

0 · Reply

ZacksResearch Jun. 11 at 11:31 AM

0 · Reply

ZacksResearch Jun. 9 at 1:35 PM

0 · Reply

ZacksResearch Jun. 9 at 1:33 PM

0 · Reply

ZacksResearch Jun. 9 at 11:45 AM

0 · Reply

Thefunnyinvestor Jun. 5 at 9:33 PM

$HOLX

0 · Reply

Truman2332 Jun. 4 at 3:01 PM

$HOLX still holding my short position… being patient for mid 50s

1 · Reply

Traderoca Jun. 4 at 2:31 PM

$HOLX

0 · Reply

ZacksResearch Jun. 4 at 2:02 PM

$HOLX struggles with Breast Health segment — what's the outlook? 🤔 Sales fell 6.2% in Q2 FY2025, with ongoing softness due to weaker capital equipment sales. Yet, management expects growth in Q4, signaling optimism for the next fiscal year and beyond. Understand the risks before investing in HOLX 👉 https://www.zacks.com/commentary/2484210/hologic-navigates-breast-health-slump-is-the-growth-thesis-intact?cid=sm-stocktwits-2-2484210-body&ADID=SYND_STOCKTWITS_TWEET_2_2484210_BODY

0 · Reply

ZacksResearch Jun. 4 at 11:43 AM

Breast Health weakness isn’t killing the $HOLX story — here’s why 📉➡️📈 Service revenue is climbing, Endomag adds firepower, and fresh tech is in the pipeline. Is the growth thesis still intact? Full breakdown here 👉 https://www.zacks.com/stock/news/2484210/hologic-navigates-breast-health-slump-is-the-growth-thesis-intact?cid=sm-stocktwits-2-2484210-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2484210_TEASER

0 · Reply

Estimize Jun. 3 at 2:01 PM

Wall St is expecting 1.05 EPS for $HOLX Q3 [Reporting 07/23 AMC] http://www.estimize.com/intro/holx?chart=historical&metric_name=eps&utm_co

0 · Reply

Vapor83 Jun. 2 at 5:03 AM

$HOLX $18.8B and it gets approved

1 · Reply

twincam May. 31 at 3:02 AM

$HOLX 🚨 $HOLX jumps on $16B buyout buzz from TPG & Blackstone 👀 📈 Stock spikes +15% 😶 Options market? Still quiet. 💼 Deal not confirmed → institutions stay in stock 💸 OI + volume light = wait-and-see mode Big move, but traders need proof.

2 · Reply

Traderoca May. 30 at 1:14 PM

$HOLX This non binding "offer" was made public to pump the stock prior to June 4 conference... The raise in price could offset any dissapointing outcome then... Money for nothing... Real price should be under 52...

0 · Reply

Truman2332 May. 30 at 3:55 AM

$HOLX “could” be revived. mid 50s coming very soon imo “We think that an acquisition by another medtech company is possible but less likely in our view given potential antitrust issues due to [Hologic's] very high mammography market share in the U.S. and its slower revenue growth," Matson wrote in a report on the matter. Citing people familiar with the matter, the publication reported that there was a chance deal talks could be revived.” https://www.mddionline.com/ma/hologic-rejects-16b-go-private-offer-from-tpg-blackstone-sparking-medtech-buzz

0 · Reply

Thefunnyinvestor May. 29 at 8:32 PM

$HOLX

0 · Reply

Traderoca May. 29 at 11:43 AM

$HOLX A nonbiding offer is in fact just noise!

0 · Reply

Traderoca May. 28 at 8:15 PM

$HOLX Game over...back to reality. This was the ultimate pump....on NOTHING!..Welcome bagholders!

1 · Reply

Traderoca May. 28 at 6:38 PM

$HOLX THE ULTIMATE PUMP METHOD!

0 · Reply

Traderoca May. 28 at 6:36 PM

$HOLX These days..you don t need to sell ..Only mention you rejected a "buyer".. and collect the profit...from suckers..🤣🤣🤣

0 · Reply

Market Cap	14.26B
Revenue (ttm)	4.03B
Net Income (ttm)	789.50M
EPS (ttm)	N/A
PE Ratio	15.53
Forward PE	15.25
Profit Margin	19.59%
Debt to Equity Ratio	0.55

Volume	5,573,100
Avg Vol	3,736,914
Day's Range	N/A - N/A
Shares Out	222.85M
Stochastic %K	37%
Beta	0.55
Analysts	Sell
Price Target	$68.27